Spots Global Cancer Trial Database for skin neoplasm
Every month we try and update this database with for skin neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions | NCT01167998 | Malignant Melan... Pigmented Nevi Skin Neoplasm | 18 Years - | Hadassah Medical Organization | ||
| A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma | NCT02302339 | Melanoma | glembatumumab v... glembatumumab v... glembatumumab v... glembatumumab v... | 18 Years - | Celldex Therapeutics | |
| PLANNED VISUAL EDUCATION ABOUT SKIN CANCER | NCT05788939 | Skin Neoplasm | Planned Visual ... | 18 Years - 24 Years | Celal Bayar University | |
| School-based Randomized Trial of SunSmart Interventions | NCT04176237 | Skin Neoplasm | UV Dosimetry La... | - | University of Southern California | |
| Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance | NCT03666325 | Skin Neoplasm | Pembrolizumab Cetuximab | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients | NCT02602067 | Breast Neoplasm Head and Neck N... Skin Neoplasm Respiratory Tra... Urogenital Neop... Digestive Syste... Pancreatic Neop... Connective and ... Lymphoma, Non-H... | 131I-Tenatumoma... | 18 Years - 75 Years | sigma-tau i.f.r. S.p.A. | |
| A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma | NCT02302339 | Melanoma | glembatumumab v... glembatumumab v... glembatumumab v... glembatumumab v... | 18 Years - | Celldex Therapeutics | |
| Impact of Sunscreen Dispensers in Parks Visited by Teenagers | NCT05908435 | Skin Neoplasm Adolescent Beha... Sunscreening Ag... | Dispensers, Fly... | 12 Years - 18 Years | Harvard School of Public Health (HSPH) | |
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients | NCT02602067 | Breast Neoplasm Head and Neck N... Skin Neoplasm Respiratory Tra... Urogenital Neop... Digestive Syste... Pancreatic Neop... Connective and ... Lymphoma, Non-H... | 131I-Tenatumoma... | 18 Years - 75 Years | sigma-tau i.f.r. S.p.A. | |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma | NCT02550678 | Basal Cell Nevu... Skin Neoplasm Nodular Basal C... | ASN-002 5-FU | 18 Years - | Ascend Biopharmaceuticals Ltd | |
| EPR Tumor Oximetry With CE India Ink | NCT03321903 | Neoplasms, Mali... Breast Neoplasm Carcinoma, Basa... Carcinoma, Squa... Melanoma Skin Neoplasm Head and Neck N... | Carlo Erba Ink ... EPR Oximetry Me... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| PLANNED VISUAL EDUCATION ABOUT SKIN CANCER | NCT05788939 | Skin Neoplasm | Planned Visual ... | 18 Years - 24 Years | Celal Bayar University | |
| EPR Tumor Oximetry With CE India Ink | NCT03321903 | Neoplasms, Mali... Breast Neoplasm Carcinoma, Basa... Carcinoma, Squa... Melanoma Skin Neoplasm Head and Neck N... | Carlo Erba Ink ... EPR Oximetry Me... | 18 Years - | Dartmouth-Hitchcock Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
